A shot of PCSK9 inhibitor before entering the health insurance is about 1,300 yuan, after entering the health insurance a shot ranging from 250 to 300 yuan, hospital level and different regions, the charges also fluctuate.
At present, there are two kinds of PCSK9 inhibitors on the market in China: eloxizumab and aliskirenzumab, both of which are potent lipid-lowering drugs. Before entering the medical insurance, a shot costs about 1,300 yuan, and after entering the medical insurance, a shot only costs 250-300 yuan.
PCSK9 inhibitors are given by injection, which can promote the degradation of cholesterol in the liver to achieve the purpose of blood lipid degradation, and can be used twice a month.
To summarize, the current price of one injection of PCSK9 inhibitor is about 250-300 yuan, the specific price refer to the local hospital charges. If there is any discomfort, it is recommended to consult a doctor in time and follow the doctor’s instructions.